Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Res Vet Sci ; 149: 94-101, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-35777285

RESUMO

Puberty is part of physiological processes including growth, adrenarche, menarche, energy balance and metabolism. This study describes the dynamic between both metabolic and reproductive statutes during pubertal growth in Saharan breed sheep. Once weaned (3 months age), two lots of lambs are made up and each one receive a barley supplementation ration of 250 vs 500 g/head/day in addition to season's diet. Biometric measurements and blood samples are collected once a month from 3 to 12 months of age in order to evaluate biochemical and sexual hormonal status. Results show a significant weight gain and growth level in the double dose lot. Changes in biochemical parameters are closely related with age at least for glycemia and total proteinemia. Androgenic profile shows individual fluctuations (0.02 to 3.47 µg /ml) due to age, season and feeding ratio. In accordance with our findings, the diet effect is clearly evidenced between the two batches, it's noted that plasma concentration of androgens is the lowest (<0.30 ng /ml) at 3 months and increases to 0.53 vs 0.76 ng /ml between 4 and 6 months confirming the pre-pubertal phase. Also, biometric and biochemical parameters are tightly correlates with plasma androgen changes, depending on whether the animal be pubescent or not. In conclusion, although interesting this study shows no early puberty onset in the barley supplemented lambs as was reported in other sheep breeds; nevertheless, the testis activity as well as the body fitness have clearly be enhance. The synergy between biochemical profiles and biometric measurements explain the metabolic function of testicular androgens at puberty.


Assuntos
Androgênios , Hordeum , Animais , Biometria , Feminino , Masculino , Valor Nutritivo , Melhoramento Vegetal , Maturidade Sexual/fisiologia , Ovinos
2.
Steroids ; 155: 108574, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31901422

RESUMO

BACKGROUND: The importance of the present study comes from the lack of sufficient information about the reversibility of the potential hepatic histopathological alterations which may result from anabolic androgenic drugs abuse by "Cycling" protocol. So, the aim of this study is to explore the negative effects of Deca-Durabolin abuse in hepatic function and structure during an administration cycle. METHODS: For our purpose, study was performed on 40 male adult mices. Animals were divided into five groups of 8 animals each treated weekly by Deca-Durabolin (nandrolone decanoate) at 30 g/kg of BW during one month (GI); during two months (GII); during three months (GIII); during three months followed by six weeks of treatment discontinuation (GIV) and Control (C). Plasma assay of liver enzymes (ALT and AST) and cytohistological examination to determine the histopathological damage properties of the liver were performed. RESULTS: Our results showed that the animals supported very well the administrated substance. Our study showed an increase in plasma levels of liver enzymes (ALT and AST) with the duration of treatment accompanied by important degenerative changes in hepatic tissue with peliosis evolution after two months of treatment. These damages worsen again 6 weeks after stopping treatment and ended by the development of hepatic steatosis with increases hepatic distress. CONCLUSION: These results ported that the use of AAS with "Cycling" may lead to the development of hepatic steatosis before progressing to more serious pathological liver situations in AAS abusers.


Assuntos
Anabolizantes/efeitos adversos , Androgênios/efeitos adversos , Fígado Gorduroso/induzido quimicamente , Decanoato de Nandrolona/efeitos adversos , Alanina Transaminase/sangue , Anabolizantes/administração & dosagem , Androgênios/administração & dosagem , Animais , Aspartato Aminotransferases/sangue , Modelos Animais de Doenças , Fígado Gorduroso/metabolismo , Masculino , Camundongos , Decanoato de Nandrolona/administração & dosagem , Detecção do Abuso de Substâncias
3.
Steroids ; 155: 108571, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31901424

RESUMO

BACKGROUND: The importance of the present study comes from the lack of sufficient information about the reversibility of the potential histopathological alterations which may result from anabolic androgenic drugs abuse by "Cycling" protocol. So, the aim of this study is to explore the negative effects of Deca-Durabolin abuse in cardiac and gonadal ultra-structures during an administration cycle. METHODS: For our purpose, study was performed on 40 male adult mices. Animals were divided into five groups of 8 animals each treated weekly by Deca-Durabolin (nandrolone decanoate) at 30 g/kg of BW during one month (GI); during two months (GII); during three months (GIII); during three months followed by six weeks of treatment discontinuation (GIV) and Control (C). Cytohistological examinations to determine the histopathological damage properties of the heart and tests were performed. RESULTS: Our results showed that the animals supported very well the administrated substance. Our study showed important degenerative changes in cardiac and gonadal tissues after one months of androgen abuse. These damages increases with the duration of treatment with well marked cell lesions, and worsen again 6 weeks after stopping treatment in cardiac tissue, whereas the gonadal tissue does not recover completely during this period. CONCLUSION: These results ported that the use of AAS with "Cycling" may lead to irreversibly destroy the heart tissue. Either, "Cycling" does not ensure the complete recovery of fertility in AAS abusers.


Assuntos
Anabolizantes/farmacologia , Androgênios/farmacologia , Gônadas/efeitos dos fármacos , Coração/efeitos dos fármacos , Decanoato de Nandrolona/farmacologia , Anabolizantes/administração & dosagem , Androgênios/administração & dosagem , Animais , Modelos Animais de Doenças , Gônadas/patologia , Masculino , Camundongos , Decanoato de Nandrolona/administração & dosagem , Detecção do Abuso de Substâncias
4.
Biomed Pharmacother ; 106: 917-922, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30119263

RESUMO

The importance of the present study comes from the lack of sufficient information about the reversibility of the histopathological alterations which may result from anabolic androgenic drugs abuse after some times of stop treatment, as it is one of the prior studies which explored the negative effects of Deca-Durabolin abuse in particular on the hearts, kidneys and testis structures. For this aim, study was performed on 40 male adult mices. Animals were divided into five groups of 8 animals each as follows: treated by Deca-Durabolin (nandrolone decanoate) at 30 g/kg of BW, weekly during one month (GI); two months (GII); three months (GIII); three months followed by six weeks of treatment discontinuation (GIV) and Control (C). Cytohistological exam was performed to determine histopathological damage in heart, kidney and testis tissues. Results showed that the treated animals supported very well the administrated substance. The increase in muscle strength and the absence of aggression were the most noticeable traits in longer-term treated groups. In addition, the gains in body and heart weights increase with duration of treatment and even more after stopping treatment. Our study showed important degenerative changes and disorganization of the histological structure of heart, kidney and testis in the animals of GIII. These damages worsen again 6 weeks after stopping treatment in heart and kidney, and repairs incompletely in the testis. In conclusion, these results confirmed that the use of AAS is associated with a lot of deleterious effects on the cardiac, nephritic and gonadic tissues which cannot be reversible.


Assuntos
Anabolizantes/toxicidade , Cardiomiopatias/induzido quimicamente , Coração/efeitos dos fármacos , Rim/efeitos dos fármacos , Decanoato de Nandrolona/toxicidade , Transtornos Relacionados ao Uso de Substâncias/patologia , Testículo/efeitos dos fármacos , Animais , Cardiomiopatias/patologia , Cardiotoxicidade , Rim/patologia , Masculino , Camundongos , Força Muscular/efeitos dos fármacos , Miocárdio/patologia , Tamanho do Órgão , Medição de Risco , Testículo/patologia , Fatores de Tempo , Aumento de Peso/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...